Company: TUTH
Filing Date: 2025-10-01
Form Type: 1-SA
Source: 0001683168-25-007356
Chunk: 8

Company: Standard Dental Labs Inc.
Filing Date: 2025-10-01
Form: 1-SA
Chunk 8
---
 Net loss per common share - basic and diluted                  |     | $                        |      (0.01 | ) |     | $ |      (0.01 | ) |
| Weighted average common shares outstanding - basic and diluted |     |                          | 30,649,653 |   |     |   | 22,429,275 |   |

| 6 |

Liquidity and Financial Condition

As of June 30, 2025, we had cash of $67,626 and
negative working capital of $2,642,832. Through June 30, 2025, the Company financed its operations primarily through proceeds from the
sales of its equity securities and convertible notes through private placements and cash flow from its dental lab operations.

The Company believes that its current levels of
cash will not be sufficient to meet its anticipated cash needs for its operations for at least the next 12 months. The Company will require
additional capital resources to fund its operations and pay its obligations as they come due over the next twelve months. The Company
may also need to implement a strategy to expand its business or other investments or acquisitions. The Company may sell additional equity
or debt securities or enter into a debt facility to satisfy its capital requirements. The sale of additional equity securities could result
in dilution to its shareholders. The incurrence of indebtedness would result in increased debt service obligations and could require the
Company to agree to operating and financial covenants that would restrict its operations. Financing may not be available in amounts or
on terms acceptable to the Company if at all. Any failure by the Company to raise additional funds on terms favorable to it, or at all,
could limit its ability to expand its business operations and could harm its overall business prospects.

Cash Provided (used in) Operating Activities

During the six months ended June 30, 2025, cash
used in operating expenses was $(49,140), and consisted of our net loss of $(424,347) offset by depreciation of $10,246, accounts payable
and other liabilities of $224,967, accounts receivable of $(10,951), prepaid expenses of $(1,520), convertible notes of $84,677, interest
on convertible notes of $25,184 and convertible note- shareholder, net of $42,604. During the six months ended June 30, 2024 cash used
in operating expenses was $(151,731), and consisted of our net loss of $(283,541)